Goldman Sachs’s RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS DRGS Stock Holding History

Goldman Sachs’s Portfolio DRGS Stock Details DRGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-7,350	Closed	-$374K	–	7511
2014 Q3	$374K	Buy	+7,350	New	+$363K	﹤0.01%	5545

Other funds holding DRGS

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Goldman Sachs's DRGS Position: Q4 2014 in Review

Goldman Sachs sold out of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) in Q4 2014, closing a stake of 7,350 shares — an estimated $374K sold.

Goldman Sachs first reported a position in DRGS in Q3 2014 and held it in 1 quarter. The position peaked at $374K in Q3 2014. 4 funds tracked by Wall St. Rank hold DRGS as of Q4 2014.

Goldman Sachs reported no remaining RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position as of Q4 2014 after selling out during the quarter.
Goldman Sachs sold 7,350 RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS shares in Q4 2014, an estimated $374K.
Goldman Sachs first reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in Q3 2014 and held it in 1 quarter.
Goldman Sachs's RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position peaked at $374K in Q3 2014.
4 funds tracked by Wall St. Rank held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS as of Q4 2014.

Based on Goldman Sachs's 13F filing for Q4 2014, filed 13 Feb 2015.